Funds and ETFs Foresee Pharmaceuticals Co., Ltd.

6576

TW0006576002

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 23:00:00 08/05/2024 BST			5-day change	1st Jan Change
93.8 ^TWD	-0.64%		-2.19%	-2.49%

05-03	Foresee Pharmaceuticals Co., Ltd. announced that it expects to receive $7.841 million in funding	CI
04-30	Foresee Pharmaceuticals Announces First Subject Dosed in Its First-In-Human Clinical Trial of FP-020	CI

ETFs positioned on Foresee Pharmaceuticals Co., Ltd.

Name	Weight	AuM	1st Jan change	Investor Rating
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	0.00%	0 M€	+3.48%	-

Foresee Pharmaceuticals Co., Ltd. is a Taiwan-based company mainly engaged in the research and development of new pharmaceuticals. The Company's main products include prostate cancer treatment product FP-001 and asthmatic/chronic obstructive pulmonary disease treatment product FP-025. It also engages in new pharmaceuticals clinic trial business.

Sector

Biotechnology & Medical Research

Calendar

09/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Foresee Pharmaceuticals Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

93.8 TWD

Average target price

153 TWD

Spread / Average Target

+63.11%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
FORESEE PHARMACEUTICALS CO., LTD.	-2.49%	396M
MODERNA, INC.	+23.37%	46.71B
LONZA GROUP AG	+48.83%	41.8B
IQVIA HOLDINGS INC.	-0.94%	41.52B
CELLTRION, INC.	-5.86%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.29%	25.78B
ALNYLAM PHARMACEUTICALS, INC.	-20.92%	19.26B
BIO-TECHNE CORPORATION	+3.20%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.67%	12.08B
MEDPACE HOLDINGS, INC.	+30.23%	11.98B